Search

Displaying results 8231 - 8240 of 10000 in total
  1. Drug

    CP-609754

    go.drugbank.com/drugs/DB12640
    Investigational

    LNK 754 has been investigated in Mild Alzheimer's Disease.

  2. Drug

    AN-2718

    go.drugbank.com/drugs/DB12810
    Investigational

    An2718 has been used in trials studying Tinea Pedis.

  3. Drug

    Irdabisant

    go.drugbank.com/drugs/DB12900
    Investigational

    Irdabisant has been used in trials studying Cognitive Impairment.

  4. Drug

    Plocabulin

    go.drugbank.com/drugs/DB13137
    Investigational

    PM060184 has been used in trials studying Solid Tumors.

  5. Drug

    PD-168393

    go.drugbank.com/drugs/DB07662
    Experimental

    PD-168393 is an epidermal growth factor receptor inhibitor.

  6. Drug

    Farabursen

    go.drugbank.com/drugs/DB18127
    Investigational

    RGLS-8429 is an investigational anti-miR-17 oligonucleotide.

  7. Drug

    ST266

    go.drugbank.com/drugs/DB18614
    Investigational

    ST266 is an amniotic membrane-derived cellular cytokine solution.

  8. Drug

    Velusetrag

    go.drugbank.com/drugs/DB12702
    Investigational

    Velusetrag has been used in trials studying the treatment of Gastroparesis and Alzheimer's Disease. … It is a highly selective serotonin receptor agonist effective in patients with chronic constipation. It is being developed by Theravance.

  9. Drug

    Icenticaftor

    go.drugbank.com/drugs/DB21466
    Investigational

    Icenticaftor is under investigation in clinical trial NCT04396366 (Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of QBW251 in Subjects With Bronchiectasis). … The usage of the INN stem '-caftor' in the name indicates that Icenticaftor is a Cystic fibrosis transmembrane regulator (CFTR) protein modulator, corrector, and amplifier.

  10. Drug

    Linvencorvir

    go.drugbank.com/drugs/DB21544
    Investigational

    The usage of the INN stem '-corvir' in the name indicates that Linvencorvir is a core protein (Cp) inhibitor. … Linvencorvir is under investigation in clinical trial NCT04225715 (A Trial To Evaluate The Efficacy And Safety Of Multiple Combination Therapies In Participants With Chronic Hepatitis B).